account_id none on file
legal_name Radiopharm Theranostics Ltd
ticker RADX
cik 1949257
domain radiopharmtheranostics.com
linkedin_company_url https://www.linkedin.com/company/radiopharm-theranostics
entry_point_account_id none on file
name Radiopharm Theranostics Limited
exchange Nasdaq
calls 0 filings 4 executives 0 family 0
why_nownone on file
callsnone on file
filings
Hains has served as our Chief Financial Officer and Joint Company Secretary since February 2021 and as a Director since March 2024.
filing / Sep 18, 2025 / receipt
Hains, a Director of Acclime Australia, is Radiopharm’s Chief Financial Officer and has been a Director of Radiopharm since March 2024.
filing / Sep 18, 2025 / receipt
there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost
filing / Sep 18, 2025 / receipt
and expense management. We anticipate that we will require substantial additional funds in order to achieve our long-term goals and complete the research and development of our current drug candidates.
filing / Sep 18, 2025 / receipt
executivesnone on file
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
slug radiopharm-theranostics-limited
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$